Switch to:
More From Other Websites
REPROS THERAPEUTICS INC. Financials Mar 20 2015
Repros (RPRX) Incurs Narrower-than-Expected Loss in Q4 - Tale of the Tape Mar 16 2015
Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2014 Financial Results Mar 16 2015
Repros Therapeutics reports 4Q loss Mar 16 2015
Repros Therapeutics reports 4Q loss Mar 16 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition Mar 16 2015
Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2014 Financial Results Mar 16 2015
Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog Mar 11 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 10 2015
Repros Files for Androxal in the U.S. for Hypogonadism - Analyst Blog Feb 03 2015
Repros Submits New Drug Application to FDA for Androxal (R) Feb 02 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Feb 02 2015
Repros Submits New Drug Application to FDA for Androxal (R) Feb 02 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Jan 12 2015
Repros Initiates Two Phase 2B Uterine Fibroid Studies Dec 29 2014
Energy Spinoffs Transocean Partners, Seventy Seven Energy Tumble Dec 29 2014
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Dec 29 2014
Repros Initiates Two Phase 2B Uterine Fibroid Studies Dec 29 2014
Repros Updates Androxal(R) Global Regulatory Status Dec 29 2014
Court Rules Inventors Correctly Named on Androxal(R) Patents Dec 29 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK